Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782548 · ClinicalTrials.gov registry record · Phase 4
Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults
A Phase 4 study, sponsored by Actavis.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00782548: Completed Phase 4 study, sponsored by Actavis.
NCT00782548 is a Phase 4 study that has completed, run by Actavis. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00782548, a Phase 4 study, has completed, sponsored by Actavis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary objective of this study was to compare the single-dose relative bioavailability of Alpharma Branded Products Division (Kadian®) and Ligand® Pharmaceuticals Inc. (AVINZA®) 30 mg morphine sulfate sustained-release capsules in healthy adult volunteers under fed conditions. The secondary objective of this study was to evaluate the adverse events associated with each of these 2 different morphine sulfate modified-release commercial formulations
Interventions
- DRUG KADIAN (morphine sulfate sustained-release) capsules
- DRUG Avinza (morphine sulfate sustained-release) capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-05 |
| Est. Completion | 2004-06 |
| Phase | Phase 4 |
What the finished NCT00782548 record still lists
NCT00782548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which KADIAN (morphine sulfate sustained-release) capsules is the first listed.
NCT00782548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00782548 about?
NCT00782548 is a clinical study titled "Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults". The primary objective of this study was to compare the single-dose relative bioavailability of Alpharma Branded Products Division (Kadian®) and Ligand® Pharmaceuticals Inc. (AVINZA®) 30 mg morphine sulfate sustained-release capsules in healthy adult volunteers under fed conditions. The secondary ob...
What is the current status of trial NCT00782548?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-05. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00782548?
The interventions under investigation include: KADIAN (morphine sulfate sustained-release) capsules (DRUG), Avinza (morphine sulfate sustained-release) capsules (DRUG).
Who is sponsoring clinical trial NCT00782548?
This trial is sponsored by Actavis, which has 79 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00782548's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia